Document
type: Class

Anualidad
type: Class

Information Content Entity
type: Class

Continuant
type: Class

Conference Poster
type: Class

Entity
type: Class

Congress communication
type: Class

Generically Dependent Continuant
type: Class

2005
type: Class

RDF description of First regimen with lopinavir/r, efavirenz or abacavir in HIV-infected patients starting HAART during 2004: Safety and efficacy. - http://research.umh.es/vivo/pub/comunicacion/32832
type: Document
rights: termsOfUse
date: 2026-08-25T15:58:38
publisher: First regimen with lopinavir/r, efavirenz or abacavir in HIV-infected patients starting HAART during 2004: Safety and efficacy.

First regimen with lopinavir/r, efavirenz or abacavir in HIV-infected patients starting HAART during 2004: Safety and efficacy.
type: Thing
RO_0002353: 10th European AIDS Conference/EACS
related by: AutorExt:57515_2005-Comunicación:32832
type: Information Content Entity
related by: AutorExt:57518_2005-Comunicación:32832
related by: Autor:35232-Comunicación:32832
most specific type: 2005
type: Conference Poster
related by: AutorExt:57514_2005-Comunicación:32832
type: Entity
related by: AutorExt:57516_2005-Comunicación:32832
type: Continuant
type: Generically Dependent Continuant
type: Congress communication
related by: AutorExt:57517_2005-Comunicación:32832
type: Document
related by: AutorExt:57513_2005-Comunicación:32832
ARG_2000028: 32832 vcard
date time value: 32832 pubdate
most specific type: Conference Poster
type: 2005
most specific type: Congress communication
type: Anualidad

10th European AIDS Conference/EACS
type: Entity
type: Event
type: BFO_0000015
type: Conference
type: Anualidad
type: BFO_0000003
RO_0002234: First regimen with lopinavir/r, efavirenz or abacavir in HIV-infected patients starting HAART during 2004: Safety and efficacy.
type: Thing
type: 2005

AutorExt:57515_2005-Comunicación:32832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: First regimen with lopinavir/r, efavirenz or abacavir in HIV-infected patients starting HAART during 2004: Safety and efficacy.

AutorExt:57518_2005-Comunicación:32832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: First regimen with lopinavir/r, efavirenz or abacavir in HIV-infected patients starting HAART during 2004: Safety and efficacy.

Autor:35232-Comunicación:32832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: First regimen with lopinavir/r, efavirenz or abacavir in HIV-infected patients starting HAART during 2004: Safety and efficacy.

AutorExt:57514_2005-Comunicación:32832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: First regimen with lopinavir/r, efavirenz or abacavir in HIV-infected patients starting HAART during 2004: Safety and efficacy.

AutorExt:57516_2005-Comunicación:32832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: First regimen with lopinavir/r, efavirenz or abacavir in HIV-infected patients starting HAART during 2004: Safety and efficacy.

AutorExt:57517_2005-Comunicación:32832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: First regimen with lopinavir/r, efavirenz or abacavir in HIV-infected patients starting HAART during 2004: Safety and efficacy.

AutorExt:57513_2005-Comunicación:32832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: First regimen with lopinavir/r, efavirenz or abacavir in HIV-infected patients starting HAART during 2004: Safety and efficacy.